Log in

Relevant bibliographies by topics / Pharmaceutical industry / Journal articles

Journal articles on the topic 'Pharmaceutical industry'

To see the other types of publications on this topic, follow the link: Pharmaceutical industry.

Author: Grafiati

Published: 4 June 2021

Last updated: 30 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Pharmaceutical industry.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Harsha, Alwin S. Kumar, Srihari Jwalapuram, and Sravan Kumar. "Marketing strategies in the pharmaceutical industry." Scientific Temper 14, no. 04 (December 27, 2023): 1526–30. http://dx.doi.org/10.58414/scientifictemper.2023.14.4.67.

Full text

Abstract:

Marketing is believed to maintain a steady supply of customers, which a business requires to survive. Pharmaceuticals are a global force; they include everything from domestic items to drugs and medical supplies that can save lives. Due to the dependence of the pharmaceutical industry on specialized training, pharmaceutical education is now a requirement for medical school. Distribution or marketing of pharmaceuticals makes drugs accessible to the public. Since most customers only actively seek out pharmaceuticals or medical supplies when they have an urgent need, pharma marketing is distinctive. Today, selling medications for a profit confronts this greatest obstacle. This Review article will examine the fundamental values of pharmaceutical marketing to comprehend it better. The study will also evaluate marketing materials for pharmaceuticals. This study draws on the knowledge of various academics and pharmaceutical marketing executives. The research focuses on the marketing balance, consumer drug attitudes, eco-friendly marketing, and pharmaceutical product promotion. The author’s choices and availability may necessitate that the examined articles and literature accurately reflect the study’s implication, and the findings may be suggestive rather than conclusive.

APA, Harvard, Vancouver, ISO, and other styles

2

Vasudha, V., and A. R. Laiju. "A Sustainable Approach Towards Wastewater Treatment in Pharmaceutical Industry: A Review." IOP Conference Series: Earth and Environmental Science 1326, no. 1 (June 1, 2024): 012137. http://dx.doi.org/10.1088/1755-1315/1326/1/012137.

Full text

Abstract:

Abstract Effluents from the pharmaceutical industry have become more concerned in recent years due to rising worries about the presence and management of pharmaceutical pollutants, raw materials, intermediates, and solvents. The pharmaceutical industry is one of the largest water consumers due to the many processes that require water. Different drug and pharmaceutical production methods result in wastewater containing a wide range of chemicals such as diclofenac, ibuprofen, carbamazepine, and clorfibric acid are commonly found in water and wastewater. As part of wastewater management, it is essential to analyse and design techniques for treating pharmaceutical wastewater in light of the limited available water resources. Furthermore, the industry mandates the reuse of water after impurities such as pharmaceuticals and other toxins. In our study, the main sources of wastewater in the pharmaceutical sector are identified, and the most effective removal technologies are examined and evaluated with the assistance of the study results. Bulk medications, pharmaceutically active substances, and other pharmaceuticals generate wastewater that utilizes much water. This effluent has been analyzed, and solutions for recovering valuable molecules to a considerable extent have been proposed. Finally, the treatment of wastewater has been addressed. Due to the shortcomings of traditional treatment techniques, the authors modified the conventional treatment procedure here using membrane bioreactors and cutting-edge techniques like ozonation, creating a hybrid wastewater treatment technology that may be a better alternative for treating pharmaceutical wastewater.

APA, Harvard, Vancouver, ISO, and other styles

3

Hassali, Mohamed Azmi, Kah Hay Yuen, Mohamed Izham Mohamed Ibrahim, Jia Woei Wong, Bee Hong Ng, and David Sue San Ho. "Malaysian Pharmaceutical Industry: Opportunities and Challenges." Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 6, no. 3 (May 2009): 246–52. http://dx.doi.org/10.1057/jgm.2009.12.

Full text

Abstract:

A sound generic pharmaceutical industry is vital for any country in order to increase the access and affordability of pharmaceuticals to the society at large. In this context, the generic pharmaceutical industry in Malaysia is seen as one of the potential manufacturing sectors that contributes not only to the well-being of the population but also in terms of economic output to the nation. However, the viability of the generic pharmaceutical industry in Malaysia is not free from challenges. In this paper, an overview of the Malaysian pharmaceutical industry together with the opportunities and challenges facing the generic market will be discussed.

APA, Harvard, Vancouver, ISO, and other styles

4

DOLENINA, Ol'ga E., and Viktoriya D. PEREVALOVA. "Innovative processes in the German pharmaceutical industry." Economic Analysis: Theory and Practice 22, no. 7 (July 31, 2023): 1384–96. http://dx.doi.org/10.24891/ea.22.7.1384.

Full text

Abstract:

Subject. The article addresses Germany's competitive position in the global pharmaceutical market and R&D development in the pharmaceutical industry. Objectives. The purpose is to provide a unique comprehensive study of innovative processes development in the pharmaceutical industry, using the case of German companies, explore innovative approaches to solving production problems, identify leading German companies in the field of biotechnology, and reveal the most promising areas for the development of German pharmaceuticals. Methods. We employ statistical and cartographic methods, and methods of comparative and economic analysis. Results. In their activities, German pharmaceutical companies combine the production of medicines, medical equipment, innovative developments, and implementation of various treatment, therapy and diagnostic programs. In a highly competitive global generic market, in Germany, there is a trend towards intra-industry structural transformation of pharmaceutical companies. The paper analyzed R&D spending, the geography of research centers of German pharmaceutical companies in the world, and their activities. Conclusions. The specifics of German pharmaceutical industry is the manufacture of high-tech products, using medical biotechnologies, which provides the country's advantage in the world market. Despite the presence of competitors in the generic market, i.e. India and China, German biotechnology-based pharmaceuticals continue to be in high demand among consumers as a high-quality product.

APA, Harvard, Vancouver, ISO, and other styles

5

Šuleková, M., M. Smrčová, A. Hudák, M. Heželová, and M. Fedorová. "Organic Colouring Agents in the Pharmaceutical Industry." Folia Veterinaria 61, no. 3 (September 1, 2017): 32–46. http://dx.doi.org/10.1515/fv-2017-0025.

Full text

Abstract:

AbstractFood dyes are largely used in the process of manufacturing pharmaceutical products. The aim of such a procedure is not only to increase the attractiveness of products, but also to help patients distinguish between pharmaceuticals. Various dyes, especially organic colouring agents, may in some cases have a negative impact on the human body. They are incorporated into pharmaceutical products including tablets, hard gelatine capsules or soft gelatine capsules, lozenges, syrups, etc. This article provides an overview of the most widely used colouring agents in pharmaceuticals, their characteristics and the EU legislation which regulates their use.

APA, Harvard, Vancouver, ISO, and other styles

6

Scherer, F. M. "Pricing, Profits, and Technological Progress in the Pharmaceutical Industry." Journal of Economic Perspectives 7, no. 3 (August 1, 1993): 97–115. http://dx.doi.org/10.1257/jep.7.3.97.

Full text

Abstract:

The decades-old debate over pharmaceutical industry prices, profits, and innovation has again intensified. A number of events coalesced to refocus public interest on pharmaceuticals. Contributing to public concern were Bureau of Labor Statistics price index increases for pharmaceuticals far outpacing those for the products of other industries. Another prominent characteristic of the pharmaceutical industry has been its extraordinarily high reported profitability. This article examines the phenomena that precipitated the current pharmaceuticals debate, their historical antecedents, and the principal questions at issue. In the author's considered judgment, a pell-mell march toward regulation of pharmaceutical industry pricing could seriously impair the industry's incentives for investment in new products.

APA, Harvard, Vancouver, ISO, and other styles

7

Nasir, Fazli. "Welcome to Pharmaceutical Communications." Pharmaceutical Communications 1, no. 01 (December 31, 2022): 01. http://dx.doi.org/10.55627/pharma.001.001.0203.

Full text

Abstract:

Welcome to the inaugural issue of Pharmaceutical Communications-a biannual, open access, and peer-reviewed journal aiming to publish high-quality research articles in the field of basic & advanced pharmaceutics and pharmaceutical technology. Pharmaceutical Communications is a biannual, peer-reviewed journal published online and in print that primarily publishes research articles and reviews that focus on basic and advanced pharmaceutics. The journal accepts manuscripts related to but not limited to, the processing of pharmaceuticals, such as crystallization, lyophilization, chemical stability of drugs, pharmacokinetics, biopharmaceutics, pro-drug developments, metabolic disposition of bioactive agents, dosage form design, pharmaceutical technology, targeted drug delivery. Other topics include pharmaceutical marketing, pharmaceutical promotion, patient-provider communication, healthcare communication, patient safety, and innovations in the pharmaceutical industry. Pharmaceutical Communications primarily accepts original research articles and reviews. However, invited editorial summaries and letters to the editor are also occasionally published. The journal provides a platform for scientists, practitioners, and healthcare professionals to share their knowledge and experiences in the field of pharmaceutics. The journal also serves as a forum for discussing and debating current issues and trends in the pharmaceutical industry. The journal welcomes submissions from academics, practitioners, and industry professionals who wish to share their research and perspectives on topics related to pharmaceutics. In the last two decades, rapid technological advances have enabled researchers to investigate arcane technological phenomena and ask more profound questions. Several pharmaceutical processes involved in the manufacturing of various dosage forms are being unraveled at a rapid pace, high resolution, and with unprecedented details. Authors carrying out investigations leveraging these technologies dealing with the composition, formulation, preparation, or manufacturing and quality control of extemporaneously compounded or commercially manufactured drugs are encouraged to submit their findings to Pharmaceutical Communications. The purpose of this journal is to provide a platform to the scientific fraternity, especially regional and national academics, where they could get their studies published after a rapid, transparent, and high-quality peer review. All the articles published in Pharmaceutical Communications will be freely available to readers immediately after publication. The open-access policy of our journal is likely to increase the readership of articles and enhance their visibility and citation potential. The journal also welcomes submissions from authors from any country. Therefore, I invite you to submit your work to Pharmaceutical Communications. We look forward to receiving your submissions! Professor Dr. Fazli Nasir Editor-In-Chief Rehabilitation Communications

APA, Harvard, Vancouver, ISO, and other styles

8

Opriş, Mircea Constantin, Dana Corina Deselnicu, and Fowzi-Constantin Crasoveanu. "Romanian Market Strategies in the Pharmaceutical Industry." Proceedings of the International Conference on Business Excellence 17, no. 1 (July 1, 2023): 1404–12. http://dx.doi.org/10.2478/picbe-2023-0126.

Full text

Abstract:

Abstract Understanding the actions taken by pharmaceutical companies to counter competition requires information on how the pharmaceutical sector is built. The pharmaceutical market, mentioned in this paper, contains all companies that produce or develop pharmaceuticals or compounds that are used to produce drugs and all other participants that interact with those companies for the purpose of selling or buying a drug. It is also necessary to understand market participants and the importance of an economy for maintaining this growing sector by supporting its production and development, in order to understand the anti-competitive actions taken by pharmaceutical innovators. This case study will provide an overview of the market defined below, applied strategies, and the elements constitutive of the pharmaceutical supply chain.

APA, Harvard, Vancouver, ISO, and other styles

9

Billi Noaman, Samar, and Haissam Lakkis. "Lebanese Pharmaceuticals and Healthcare Industry: Investing in the Pharmaceutical Industry to Promote Exports." Lebanese Science Journal 23, no. 2 (December 16, 2022): 178–90. http://dx.doi.org/10.22453/lsj-023.2.178-190.

Full text

Abstract:

Compared to importation, the pharmaceutical production in Lebanon is still weak. The generics prescription is neglected according to the medicines of origin as only big brands dominate the Lebanese market. Despite the agreements between Lebanon and other Arab countries, the nature of the regulatory environment in the latter is likely to be a substantial obstacle that prevents the access of the Lebanese medicines to the markets of the Arab countries. On the other hand, the development of a new market access remains a necessity for increasing the volume of pharmaceutical exports. This paper aims to demonstrate, based on the Lebanese market analysis the significance of supporting local pharmaceutical manufacturing since it contributes as a primary factor in reducing the cost of the medical bill for citizens, public institutions, and payers. The paper concludes with a set of recommendations to strengthen the pharmaceutical sector as well as to stimulate and develop the local production of pharmaceutical medications.

APA, Harvard, Vancouver, ISO, and other styles

10

Dickov, Veselin, Dragan Mitrovic, and Boris Kuzman. "Analyzing Pharmaceutical Industry." National Journal of Physiology, Pharmacy and Pharmacology 1, no. 1 (2011): 1. http://dx.doi.org/10.5455/njppp.2011.1.1-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Ferreira De Souza, Gisele. "Pharmaceutical Industry Report." Acta Scientifci Nutritional Health 4, no. 9 (August 24, 2020): 75–77. http://dx.doi.org/10.31080/asnh.2020.04.0752.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Anegawa, Tomofumi. "Japanese Pharmaceutical Industry." Iryo To Shakai 12, no. 2 (2002): 49–78. http://dx.doi.org/10.4091/iken1991.12.2_49.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Birdwell, Stephen W., and Hazel B. Benson. "The Pharmaceutical Industry." Journal of Pharmacy Teaching 1, no. 1 (1990): 17–25. http://dx.doi.org/10.1300/j060v01n01_03.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

MCCOY, MICHAEL, and PATRICIA SHORT. "PHARMACEUTICAL INDUSTRY SHOWCASE." Chemical & Engineering News 79, no. 42 (October 15, 2001): 8. http://dx.doi.org/10.1021/cen-v079n042.p008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Deuskar, Vishwa. "Comparative Profitability Analysis: Sun Pharmaceutical Company & Cipla Pharmaceutical Company." RESEARCH REVIEW International Journal of Multidisciplinary 7, no. 8 (August 17, 2022): 109–14. http://dx.doi.org/10.31305/rrijm.2022.v07.i08.017.

Full text

Abstract:

The Indian pharmaceutical industry is growing tremendously. Indian pharmaceutical industry plays a prominent role in the global pharmaceutical industry. It contributes to the welfare of people and provides significant socio-economic benefits to the society through creation of jobs, supply chains and community development. This study has been done for important evaluation of two Indian giant pharmaceutical industries i.e. Sun pharmaceutical Ltd. and Cipla pharmaceuticals. This study focuses on to analyze the profitability of the selected pharmaceutical companies of India and to do comparative study with the help of various measures of profitability. The study period is five years 2017-18 to 2021-22. From the research study we can analyze which company needs to pay more attention towards its performance.

APA, Harvard, Vancouver, ISO, and other styles

16

Naimat, Nasihah, Mimi Sofiah Ahmad Mustafa, Nasreen Miza Hilmy Nasrijal, and Ida Rahayu Mahat. "Challenges and Opportunities in the Halal Pharmaceutical Industry in Malaysia." Information Management and Business Review 15, no. 4(I) (January 3, 2024): 73–78. http://dx.doi.org/10.22610/imbr.v15i4(i).3565.

Full text

Abstract:

Following the global significance of halal pharmaceutical products, Malaysia has positioned itself as a key manufacturer to increase industrial demand. This study examines Malaysia's halal pharmaceutical industry by internalizing consumer preferences for halal pharmaceuticals and the associated complexities. The data derived from literature reviews were subjected to documentation analysis. Consumer preference was substantially influenced by religious beliefs, product quality, and health concerns. Halal certification, cross-contamination concerns, and regulatory compliance were the key issues underlying halal pharmaceutical products. Overall, this empirical work expanded the current literature with pivotal insights into the future developments of halal pharmaceuticals in Malaysia. Industry players, policymakers, and stakeholders can utilize such knowledge to develop strategies that enhance the halal pharmaceutical industry and meet Muslim consumers’ preferences.

APA, Harvard, Vancouver, ISO, and other styles

17

Kopteva, Lyudmila, Artur Budagov, and Lyudmila Shabalina. "Russian pharmaceutical industry innovative development: present state and prospects." E3S Web of Conferences 284 (2021): 02017. http://dx.doi.org/10.1051/e3sconf/202128402017.

Full text

Abstract:

In the article the innovative development of the Russian Federation pharmaceutical industry is considered in the context of global trends and world pharmaceutical market development priority areas. The countries’ patent activity in the sphere of medical technologies and pharmaceuticals is considered. The main technological and conceptual trends in the development of the Russian pharmaceutical market have been identified. The results obtained are aimed at the Russian pharmaceutical market innovative development in the context of global instability. The practical significance of the study lies in the fact that on its basis it is possible to develop tools aimed at increasing the level of innovation in the Russian pharmaceutical industry.

APA, Harvard, Vancouver, ISO, and other styles

18

Boychev, Vladimir. "TECHNOLOGICAL FUTURE OF PHARMACEUTICAL INDUSTRY– DEVELOPMENT PERSPECTIVES." Entrepreneurship 10, no. 1 (May 15, 2022): 68–77. http://dx.doi.org/10.37708/ep.swu.v10i1.7.

Full text

Abstract:

Digital revolution and innovations are the modern phenomena pharmaceutical industry should take advantage of. The prevention of diseases will also facilitate the progress of the sector. This publication examines the key factors influencing pharmaceutical industry behavior and bears the potential to drastically change the sector in the upcoming years. The forthcoming challenges and changes appearing on the horizon require careful and precise consideration of new kinds of markets, alternative business models or even a complete change in the way pharmaceutical companies operate. The future of the industry is defined by the introduction of various technologies that are currently changing and will continue to change all aspects of the industry – production of pharmaceuticals, supply chain, clinical trials, etc. The leading tendencies in the advancement of the pharmaceutical sector in 2019-2021 are also analyzed with a focus on new technologies and digitalization. Different trends have changed the sector inevitably having both short-term and long-term impact.

APA, Harvard, Vancouver, ISO, and other styles

19

Dr. R. Perumal, Dr R. Perumal. "Fund Management in Pharmaceutical Industry in India." Indian Journal of Applied Research 1, no. 6 (October 1, 2011): 143–45. http://dx.doi.org/10.15373/2249555x/mar2012/49.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Reddy, Dr Tamma Koti. "Foreign Direct Investments in Indian Pharmaceutical Industry." Paripex - Indian Journal Of Research 2, no. 2 (January 15, 2012): 81–83. http://dx.doi.org/10.15373/22501991/feb2013/26.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Prozherina, Yuliya. "Technology and innovation in the pharmaceutical industry." Remedium. Journal about the Russian market of medicines and medical equipment, no. 1 (2021): 63–64. http://dx.doi.org/10.21518/1561-5936-2021-1-63-64.

Full text

Abstract:

Analytics In recent years, technology and innovation have moved in leaps and bounds, changing all sectors including healthcare and pharmaceutics. The use of Big Data and process automation are driving rapid progress. The most modern approaches are being introduced into pharmacies and pharmaceutical enterprises even today.

APA, Harvard, Vancouver, ISO, and other styles

22

Nezhnikova, Ekaterina V., and Maksim V. Maksimchuk. "Pharmaceutical industry in Russia: problems and prospects of development." RUDN Journal of Economics 27, no. 1 (December 15, 2019): 102–12. http://dx.doi.org/10.22363/2313-2329-2019-27-1-102-112.

Full text

Abstract:

The paper analyzes the changes in the Russian pharmaceutical market and discusses the prospects and trends of the Russian pharmaceutical industry. The purpose of the work is to identify the main directions and problems of development and functioning of the pharmaceutical industry of the Russian Federation. Over the past few years, the state has created a strategy for the development of pharmaceuticals, which can bring the industry to a new level. However, existing problems and the lack of an integrated approach hamper the fulfillment of this task. Based on the analysis, the author provides a list of recommendations to improve the efficiency of the functioning and solving the main problems of the pharmaceutical industry, special attention is paid to increasing the investment potential, strengthening the legal framework of the industry, and the importance of increasing the innovative potential of the industry.

APA, Harvard, Vancouver, ISO, and other styles

23

Doostzadeh, Ebrahim, Hussein Shabaninejad, Hesamoddin Madani, and Zahra Ahani Amineh. "A FRAMEWORK FOR EVALUATION OF PHARMACEUTICAL INDUSTRY DEVELOPMENT IN DEVELOPING COUNTRIES: EVIDENCE FROM IRAN." Asian Journal of Pharmaceutical and Clinical Research 9, no. 5 (September 1, 2016): 50. http://dx.doi.org/10.22159/ajpcr.2016.v9i5.10099.

Full text

Abstract:

ABSTRACTObjectives: The pharmaceutical market is a complex market due to its complicated supply chain and the extent of government regulations in allaspects of the trade lifecycle of drug development. Considering the importance of pharmaceuticals for society and the relevant trend of globalization,managing pharmaceutical industry effectively and efficiently is vital, particularly in developing countries. The present study determines the factorsaffecting the development of the Iranian pharmaceutical industry based on pharmaceutical mangers’ point of view.Methods: In this study, we assessed managers’ perspective about the internal and external key factors affecting the development of pharmaceuticalindustry. Finally, their perspective about the solutions for the development of pharmaceutical industry was assessed. Accordingly, a self-designedquestionnaire was sent to 65 managers at Tamin Pharmaceutical Investment Company, of which, 51 questionnaires were answered by the managers. Result: Most managers believed generic scheme reflect negatively on the development of the pharmaceutical industry and that external factors havea great impact on its improvement. They believe that branded generic transition along with supporting regulations, investment in Research andDevelopment, and joint venture with foreign companies will improve the pharmaceutical industry.Conclusion: To sum up, for improving the pharmaceutical industry in the shortest time possible, improvement of technological capabilities andinvestment in R&D should be considered.Keywords: Pharmaceutical industry, Key factors, Generic scheme.

APA, Harvard, Vancouver, ISO, and other styles

24

Gauri, Deshmukh, Umap Swati, Bhapkar Tejal, Somkuwar A. P, Dubey Sonal, More G.V, Sawarkar Alka, and Limsay R.P. "Pharmaceutical Waste a Global Challenge to Ecosystem." Chronicle of Aquatic Science 10, no. 01 (2024): 53–64. http://dx.doi.org/10.61851/coas.v1i10.05.

Full text

Abstract:

The pharmaceutical industry is one of the biggest industries, having a significant share of the world’s economy. At the same time, with the high production of pharmaceutical products, this industry is becoming a significant threat to the environment by producing vast amounts of pharmaceutical waste, which imparts specific hazardous, debilitating effects on the environment. Waste products made by the pharmaceutical industry, mainly drugs that contain active pharmacological ingredients (APIs), cause hazardous effects on the environment. Primarily, Improper disposal of expired pharmaceuticals, ampules, or vials containing amounts of drugs, unused capsules, and pills in nearby water resources is the primary reason for the pharmaceuticals to come in contact with ecosystems. Secondly, the excretions by the personnel consuming drugs also contain some or some other active metabolite of pharmaceutical agents. Certain pharmaceuticals that remain persistent in their original form or as metabolites after exposure to environmental degradation and impart harmful effects on the ecosystem in which they are present are called ‘Environmentally Persistent Pharmacological Products’ (EPPPs). The toxic effects of these EPPPs are directly imparted on birds, animals, and humans, and it is an essential concern from a public health point of view as well. Certain important case studies are also included in the article.

APA, Harvard, Vancouver, ISO, and other styles

25

Максимчук, М. В., and А. В. Кореневская. "PROSPECTS FOR THE USE OF HYDROCARBON RESOURCES IN THE PHARMACEUTICAL INDUSTRY." Scientific Journal ECONOMIC SYSTEMS 1, no. 210 (2022): 163–72. http://dx.doi.org/10.29030/2309-2076-2022-15-2-163-172.

Full text

Abstract:

The article examines the main methods of processing hydrocarbon resources in the pharmaceutical industry. Analyzed are the main factors constraining the use of raw materials obtained from the processing of hydrocarbon resources in the pharmaceutical industry. The paper deals with the problems of using petroleum products in the context of the pharmaceutical industry. The author examines the state strategy for the development of pharmaceuticals, which is able to bring the industry to a new level. However, existing problems and the lack of an integrated approach hinder the implementation of this task. On the basis of the analysis, the author provides a list of recommendations for improving the efficiency of functioning and solving the main problems of the pharmaceutical industry, special attention is focused on increasing the innovative potential of the industry due to in-depth processing of hydrocarbon resources.

APA, Harvard, Vancouver, ISO, and other styles

26

Ernawati, Ernawati. "THE GLOBAL COMPETITIVENESS STUDY OF HALAL PHARMACEUTICALS AND COSMETICS INDUSTRY." Mega Aktiva: Jurnal Ekonomi dan Manajemen 8, no. 1 (May 4, 2019): 51. http://dx.doi.org/10.32833/majem.v8i1.79.

Full text

Abstract:

This research aimed to determine the position of global competitiveness of the halal pharmaceutical and cosmetics industries. The secondary data used data about the state of the global Islamic economy 2014-2017 period from Thomson Reuters Publication. Data analyzed using charts and descriptive statistics. The data were categorized into very low ratings to very high. The results showed that (1) the highest competitiveness in global pharmaceutical and cosmetics industry was the United Arab Emirates (UEA) followed by Malaysia and then Singapore. The high global competitiveness of the UAE is driven by the government role in halal pharmaceuticals and cosmetic regulations, public awareness, and social factors. The indicator of export UEA was also in the high category of competitiveness in the global pharmaceutical and cosmetics industry, even though the value is lower than Singapore; (2) Indonesia has a major advantage in the low of costs of halal pharmaceuticals and cosmetics industry; and (3) the Muslim countries generally still have a very low-level of awareness of halal pharmaceuticals and cosmetics industry

APA, Harvard, Vancouver, ISO, and other styles

27

Ferreira De Souza, Gisele, Jair Ribeiro Dos Santos Junior, and Chinazo Amala Ezeilo. "Pharmaceutical Residues Industry Report." Acta Scientifci Nutritional Health 4, no. 5 (May 2, 2020): 53–54. http://dx.doi.org/10.31080/asnh.2020.04.0700.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Romanova, Svetlana. "Pharmaceutical industry in 2013." Remedium. Journal about the Russian market of medicines and medical equipment, no. 3 (2014): 54–59. http://dx.doi.org/10.21518/1561-5936-2014-3-54-59.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Romanova, Svetlana. "Pharmaceutical industry in 2014." Remedium. Journal about the Russian market of medicines and medical equipment, no. 4 (2015): 84–88. http://dx.doi.org/10.21518/1561-5936-2015-4-84-88.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Romanova, Svetlana. "Pharmaceutical industry in 2015." Remedium. Journal about the Russian market of medicines and medical equipment, no. 4 (2016): 61–65. http://dx.doi.org/10.21518/1561-5936-2016-4-61-65.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Romanova, Svetlana. "Pharmaceutical industry in 2016." Remedium. Journal about the Russian market of medicines and medical equipment, no. 4 (2017): 74–78. http://dx.doi.org/10.21518/1561-5936-2017-4-74-78.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Meshkovsky, A. P., N. V. Pyatigorskaya, Z. I. Aladysheva, and N. S. Ivashechkova. "Pharmaceutical industry in India." Remedium. Journal about the Russian market of medicines and medical equipment, no. 5 (2017): 6–10. http://dx.doi.org/10.21518/1561-5936-2017-5-6-10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Marlow, Hilary F. "The Pharmaceutical Industry Viewpoint." Cardiology 85, no. 1 (1994): 102–12. http://dx.doi.org/10.1159/000176769.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Crane, Vicki S., Kathryn K. Jefferson, and Rob Morgan. "Rethinking pharmaceutical industry relationships." American Journal of Health-System Pharmacy 44, no. 8 (August 1, 1987): 1884–901. http://dx.doi.org/10.1093/ajhp/44.8.1884.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Goodman, Michael. "Pharmaceutical industry financial performance." Nature Reviews Drug Discovery 8, no. 12 (December 2009): 927–28. http://dx.doi.org/10.1038/nrd3049.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Maynard, A., and K. Bloor. "Regulating the pharmaceutical industry." BMJ 315, no. 7102 (July 26, 1997): 200–201. http://dx.doi.org/10.1136/bmj.315.7102.200.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Furniss, J., J. Zammit-Lucia, N. Johnson, P. Read, A. Towse, P. Rowlatt, P. R. Clear, et al. "Regulating the pharmaceutical industry." BMJ 316, no. 7126 (January 17, 1998): 226. http://dx.doi.org/10.1136/bmj.316.7126.226.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Carnevale, Richard A., and Thomas R. Shryock. "Animal health pharmaceutical industry." Preventive Veterinary Medicine 73, no. 2-3 (February 2006): 217–20. http://dx.doi.org/10.1016/j.prevetmed.2005.09.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Raskin, Philip. "Pharmaceutical Industry Sponsored Symposia." Journal of Diabetes and its Complications 7, no. 2 (April 1993): 65–66. http://dx.doi.org/10.1016/1056-8727(93)90027-v.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Cooper, Theodore. "Perspectives: The Pharmaceutical Industry." Health Affairs 7, suppl 2 (January 1988): 92–95. http://dx.doi.org/10.1377/hlthaff.7.2.92.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Wurm, Jeremy. "Australian pharmaceutical industry observed." Nature 369, no. 6477 (May 1994): 259–60. http://dx.doi.org/10.1038/369259a0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Teng, Che-Ming. "Pharmaceutical Infrastructure and Industry." Asia-Pacific Biotech News 11, no. 12 (June 30, 2007): 845–49. http://dx.doi.org/10.1142/s0219030307000882.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Cocolas, George H. "Pharmaceutical Industry and Academia." American Journal of Pharmaceutical Education 50, no. 2 (1986): 212–13. http://dx.doi.org/10.1016/s0002-9459(24)02401-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Mamedyarov, Z. A. "Pharmaceutical Industry Development in the Midst of Crisis: Global Trends." MIR (Modernization. Innovation. Research) 11, no. 4 (December 28, 2020): 398–408. http://dx.doi.org/10.18184/2079-4665.2020.11.4.398-408.

Full text

Abstract:

Purpose: the main purpose of the article was to study the trends in the global pharmaceutical industry, as one of the most knowledge-intensive in the world economy, against the background of the 2020 COVID-related crisis. The task was to study the impact of the economic crisis on the priorities of the largest pharmaceutical multinationals, to link them with trends in the restructuring of health care systems, as well as to analyze and assess the potential impact of Brexit on the European pharma industry, starting from 2021.Methods: the work is based on a comparative analysis of trends in the restructuring of global value chains in pharmaceuticals, the digitalization of pharmaceuticals and health care, as well as a quantitative analysis of the revenue and value added by the largest European pharmaceutical multinational companies.Results: the COVID-19 pandemic has accelerated the process of digitalization of big pharma; the intensified transition to a continuous production model can be expected in the coming years. Also, the second largest industry market, the EU-27, will suffer less from Brexit than the UK itself, and industries in developing countries will benefit from additional growth opportunities. The digitalization of healthcare remains an important underlying factor for the transformation of pharmaceuticals and further growth of innovation competition. This paper presents the problems of pharma and how to address them, as well as possible ways to restructure healthcare systems to reduce the likelihood of new pandemics – this will be at the heart of regulatory solutions in the medium term.Conclusions and Relevance: governments and state regulators will be actively involved in the process of recovery of the pharmaceutical industry after the crisis. For small regional pharmaceutical producers in developing countries there is a growing need to digitalize production and diversify supply chains. Implementation of continuous production technologies allows expecting growth in the number of small pharmaceutical producers, deepening competition in the industry. The Brexit deal will also have significant implications for the industry, leading to a restructuring of supply chains within the EU from early 2021, reducing the UK's competitiveness.

APA, Harvard, Vancouver, ISO, and other styles

45

Hoq, Meem Rafiul, Md Ali Ahsan, and Tanim–A Tabassum. "A Study on SWOT Analysis of Pharmaceutical Industry: The Bangladesh Context." Global Disclosure of Economics and Business 2, no. 2 (December 31, 2013): 200–208. http://dx.doi.org/10.18034/gdeb.v2i2.188.

Full text

Abstract:

Pharmaceutical industry is one of the most important sector in Bangladesh. It is the only industry, which has its own strong manufacturing capabilities to produce the pharmaceuticals product. In this study it is tried to find out what types of strengths, weaknesses, opportunities and threats the pharmaceuticals companies face in Bangladesh. There are about 250 pharmaceuticals firms in Bangladesh. Among them some companies are the large size and more sophisticated. Some companies are small sizes and traditional qualities. A few companies dominate the whole medicine market. So they have to face severe competition in pharmaceuticals market. SOWT (Strength, Opportunity, Weakness, and Threat) analysis of any industry sector investigates the important factors that are possibility of the industry and influencing the companies operating in that sector. The purpose of this study is to analyze the pharmaceutical sector of Bangladesh using the framework of SWOT. This paper brings to light on the SWOT analysis of pharmaceuticals industry in Bangladesh and provided some valuables suggestions to overcome the weaknesses and threats, there are some suggestions to utilize the strengths and opportunities properly. Through this study the researchers try to discuss the affect of various macro-economic factors of strength, opportunity, weakness, and threat aspect on the industry and its related problems and prospects for the future. JEL Classification Code: O25; O25

APA, Harvard, Vancouver, ISO, and other styles

46

Mamedyarov, Z. A. "Strategic Role of the Pharmaceutical Industry in the Сontext of the Global Pandemic." Journal of International Analytics 11, no. 4 (March 9, 2021): 122–36. http://dx.doi.org/10.46272/2587-8476-2020-11-4-122-136.

Full text

Abstract:

The strategic importance of the pharmaceutical industry for the scientific, technological and economic development of countries determines its impact on international processes. The paper traces the current trends in the growth of innovative competition in pharmaceuticals and biotechnology, taking into account the factor of the COVID-19 pandemic. The following areas of increased competition are highlighted: diversification of supply of active pharmaceutical substances, regulators’ permission of the newest drugs to access the market, competition of pharmaceutical companies for capital and competence. The pandemic has also exacerbated long-standing problems: the efficiency of drug distribution to citizens, the dependence of large manufacturers on active substance suppliers from China, drug pricing, and the role of social insurance systems in developed and developing countries. The article analyzes the main problems of the industry and presents possible trajectories of further development of international relations in the context of pharmaceuticals and biotechnology, analyzing the progress of creation and market admission of COVID-19 vaccines. For all the high-tech trends, the pharmaceutical industry is a rather conservative industry in which regulatory issues play a significant role. Therefore, legal, ethical and practical issues related to the collection of sensitive patient health data may slow down the digitalization of the pharmaceutical industry. Much will also depend on the decisions of major regulators – in the U.S. and the EU – regarding telemedicine and digital health in general. A serious barrier for the pharmaceutical industry is also the lack of pharmaceutical companies’ own experience in developing software solutions, which makes them dependent on external suppliers of IT solutions, complicates the problem of sharing clinical patient data and particularly raises the issue of cybersecurity.

APA, Harvard, Vancouver, ISO, and other styles

47

Tomar, Prashant, and Preeti Khothiyal. "A REVIEW ON CLEANING VALIDATION FOR PHARMACEUTICAL INDUSTRY." INDIAN RESEARCH JOURNAL OF PHARMACY AND SCIENCE 4, no. 2 (June 2017): 950–62. http://dx.doi.org/10.21276/irjps.2017.4.2.2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Bhoot, Archana J. "Impact Of Budget On Pharmaceutical Industry In India." Indian Journal of Applied Research 1, no. 12 (October 1, 2011): 4–5. http://dx.doi.org/10.15373/2249555x/sep2012/2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Bonthagarala, Brahmaiah, Sandhya Ch., Pusuluri Dharani Lakshmi Sai, and Konkipudi Venkata Sivaiah. "Process validation: An essential process in pharmaceutical industry." International Journal of Advances in Scientific Research 1, no. 4 (May 30, 2015): 179. http://dx.doi.org/10.7439/ijasr.v1i4.1781.

Full text

Abstract:

The purpose of this work is to present an introduction and general overview on process validation of pharmaceutical manufacturing process especially tablet manufacturing process with special reference to the requirements stipulated by the US Food and Drug Administration (FDA).Quality is always an imperative prerequisite when we consider any product. Therefore, drugs must be manufactured to the highest quality levels. End-product testing by itself does not guarantee the quality of the product. Quality assurance techniques must be used to build the quality into the product at every step and not just tested for at the end. In pharmaceutical industry, Process Validation performs this task to build the quality into the product because according to ISO 9000:2000, it had proven to be an important tool for quality management of pharmaceuticals.

APA, Harvard, Vancouver, ISO, and other styles

50

CONTRACTOR, SUNIL H., PIYUSH KUMAR, and THOMAS W. LEIGH. "THE IMPACT OF GOVERNANCE MECHANISMS ON ESCALATION OF COMMITMENT." International Journal of Innovation Management 16, no. 04 (July 18, 2012): 1250023. http://dx.doi.org/10.1142/s1363919612500235.

Full text

Abstract:

There are conflicting opinions on whether the existing US legal and economic environment for pharmaceutical research is conducive for the repurposing of patent-protected drugs. This article therefore addresses the following innovation policy questions: Does US patent law and regulatory policy assign sufficient value to new use patents in the pharmaceutical industry? If present law and regulatory policy does assign sufficient value, what evidence is there that the pharmaceutical industry is actively involved in technology strategies to repurpose existing pharmaceuticals? Based on an evaluation of the extant legal literature, US pharmaceutical firms are generally successful at legally enforcing their new use patents against infringement. Furthermore, the truncating of the time and resources dedicated to the drug discovery, development, and regulatory review process provide sufficient economic "value" on both the front end of the pharmaceutical regulatory approval process, and the back end of the drug patent term for encouraging pharmaceutical industry repurposing.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!